Galanin receptor antagonist M35 but not M40 or C7 ameliorates cerulein-induced acute pancreatitis in mice

Pancreatology

Volumn 10, Issue 6, 2011, Pages 682-688

  Bhandari, M ^a   Kawamoto, M ^a   Thomas, A C ^a   Barreto, S G ^a   Schloithe, A C ^a   Carati, C J ^a   Toouli, J ^a   Saccone, G T P ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Acute pancreatitis; Galanin; Galanin antagonists; Peptide therapeutics

Indexed keywords

AMYLASE; ANTIINFLAMMATORY AGENT; C 7; CERULETIDE; GALANIN RECEPTOR; GALANTIDE; M 35; M 40; MYELOPEROXIDASE; RECEPTOR BLOCKING AGENT; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREAS NECROSIS; PRIORITY JOURNAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

EID: 78651401655     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000314603     Document Type: Article

References (38)

1. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L: Pathophysiology of acute pancreatitis. Pancreatology 2005; 5: 132-144. (Pubitemid 40754730)
2. Eland IA, Sturkenboom MJ, Wilson JH, Stricker BH: Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol 2000; 35: 1110-1116.
3. Merchentaler I, Lopez FJ, Negro-Vilar A: Co-localization of galanin and luteinizing hor-mone-releasing hormone in a subset of pre-optic hypothalamic neurons: anatomical and functional correlates. Proc Natl Acad Sci USA 1990; 87: 6326-6330.
4. Lang R, Gundlach AL, Kofler B: The galanin peptide family: receptor pharmacology pleiotropic biological actions, and implica-tions in health and disease. Pharmacol Ther 2007; 115: 177-207. (Pubitemid 47042915)
5. Mitsukawa K, Lu X, Bartfai T: Galanin, galanin receptors and drug targets. Cell Mol Life Sci 2008; 65: 1796-1805.
6. Diaz-Carbiale Z, Parrado C, Vela C, Razani H, Covenas R, Fuxe K, Narvaez JA: Role of galanin and galanin (1-15) on cardiovascular control. Neuropeptides 2005; 39: 185-190. (Pubitemid 40804583)
7. Adeghate E, Ponery AS: Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats. J Neuro-endocrinol 2001; 13: 706-710. (Pubitemid 32725578)
8. Shimosegawa T, Morizumi S, Koizumi M, Kashimura J, Yanaihara N, Toyota T: Immu-nohistochemical demonstration of galanin-like immunoreactive nerves in the human pancreas. Gastroenterology 1992; 102: 263-271.
9. Lindskog S, Ahren B: Effects of galanin and norepinephrine on insulin secretion in the mouse. Pancreas 1992; 7: 636-641.
10. Ahren B, Andren-Sandberg A, Nilsson A: Galanin inhibits amylase secretion from iso-lated rat pancreatic acini. Pancreas 1988; 3: 559-562. (Pubitemid 19053247)
11. Ahren B: Autonomic regulation of islet hor-mone secretion-implications for health and disease. Diabetologia 2000; 43: 393-410. (Pubitemid 30237947)
12. Yagci RV, Alptekin N, Zacharia S, Coy DH, Ertan A, Rossowski WJ: Galanin inhibits pancreatic amylase secretion in the pento-barbital-anaesthetized rat. Regul Pept 1991; 34: 275-282.
13. Flowe KM, Lally KM, Mulholland MW: Galanin inhibits rat pancreatic amylase re-lease via cholinergic suppression. Peptides 1992; 13: 487-492.
14. Kashimura J, Shimosegawa T, Kikcuhi Y, Yo-shida K, Koizumi M, Mochizuki T, Yanai-hara N, Toyota T: Effects of galanin on amy-lase secretion from dispersed rat pancreatic acini. Pancreas 1994; 9: 258-262. (Pubitemid 24063123)
15. Brodish RJ, Kuvshinoff BW, Fink AS, Mc-Fadden DW: Inhibition of pancreatic exo-crine secretion by galanin. Inhibition of pan-creatic secretion by galanin. Pancreas 1994; 9: 297-303. (Pubitemid 24116713)
16. Kisfalvi I Jr, Racz G, Balint A, Mate M, Olah A, Zelles T, Vizi ES, Varga G: Effects of puta-tive galanin antagonists M35 and C7 on rat exocrine pancreas. J Physiol Paris 2001; 95: 385-389. (Pubitemid 33020264)
17. Herzig KH, Brunke G, Schon I, Schaffer M, Folsch UR: Mechanisms of galanins inhibi-tory action on pancreatic enzyme secretion: modulation of cholinergic transmission studies in vivo and in vitro. Gut 1993; 34: 1616-1621. (Pubitemid 23341859)
18. Rossowski WJ, Zacharia S, Jiang NY, Mun-gan Z, Mills M, Eratn A, Coy DH: Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contrac-tion. Eur J Pharmacol 1993; 240: 259-267. (Pubitemid 23255225)
19. Runzi M, Muller MK, Schmid P, von Schon-feld J, Goebell H: Stimulatory and inhibitory effects of galanin on exocrine and endocrine rat pancreas. Pancreas 1992; 13: 487-492.
20. Barreto SG, Woods C, Carati C, Schloithe AC, Jaya P, Toouli J, Saccone GTP: Galanin inhibits caerulein-stimulated pancreatic amylase secretion via cholinergic nerves and insulin. Am J Physiol 2009; 297:G333-339.
21. Bhandari M, Thomas AC, Carati CJ, Ka-wamoto M, Brooke-Smith ME, Toouli J, Saccone GTP: Galanin antagonism reduces hyperenzymemia associated with acute pancreatitis in a possum model. Gastroen-terology 2006; 130(suppl 2):A707.
22. Bhandari M, Thomas AC, Hussey DJ, Li X, Jaya SP, Woods CM, Schloithe AC, Mayne GC, Carati CJ, Toouli J, Ormandy CJ, Sac-cone GT: Galanin mediates the pathogenesis of caerulein-induced acute pancreatitis in the mouse. Pancreas 2010; 39: 182-187.
23. McGregor DP: Discovering and improving novel peptide therapeutics. Curr Opin Phar-macol 2008; 8: 616-619.
24. Rifai Y, Elder AS, Carati CJ, Hussey DJ, Li X, Woods CM, Schloithe AC, Thomas AC, Mathison RD, Davison JS, Toouli J, Saccone GT: The tripeptide analog feG ameliorates severity of acute pancreatitis in a caerulein mouse model. Am J Physiol 2008; 294:G1094-G1099. (Pubitemid 351520076)
25. Niederau C, Ferrel LD, Grendell JH: Ceru-lein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotrip and secretin. Gastroenterology 1985; 88: 1192-1204. (Pubitemid 15087622)
26. Brooke-Smith ME, Carati CJ, Bhandari M, Toouli J, Saccone GT: Galanin in the regula-tion of pancreatic vascular perfusion. Pan-creas 2008; 36: 267-273. (Pubitemid 351440931)
27. Bartfai T, Fisone G, Langel U: Galanin and galanin antagonists: molecular and bio-chemical perspectives. Trends Pharmacol Sci 1992; 13: 312-317.
28. Kolakowski LF Jr, O'Neill GP, Howard AD, Broussard SR, Sullivan KA, Feighner SD, Sawzdargo M, Nguyen T, Kargman S, Shiao LL, Hreniuk DL, Tan CP, Evans J, Abramo-vitz M, Chateauneuf A, Coulombe N, Ng G, Johnson MP, Tharian A, Khoshbouei H, George SR Smith RG, O'Dowd BF: Molecu-lar characterisation and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem 1998; 71: 2239-2251. (Pubitemid 28531233)
29. Saccone GTP, Schloithe AC, Carati CJ, To-ouli J: The specific galanin receptor 3 antag-onist SNAP-37889 (SNAP) ameliorates caer-ulein-induced acute pancreatitis (AP) in mice. Pancreas 2008; 37: 493.
30. Floren A, Land T, Langel U: Galanin receptor subtyped and ligand binding. Neuropeptides 2000; 34: 331-337. (Pubitemid 32164857)
31. Hegde A, Bhatia M: Neurogenic inflamma-tion in acute pancreatitis. JOP 2005; 6: 417-421.
32. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GTP: Galanin potentiates supra-maximal caerulein-stimulated pancreatic amylase secretion via its action on soma-tostatin secretion. Am J Physiol 2009; 297:G1268-G1273.
33. Jaya SP, Schloithe AC, Carati CJ, Toouli J, Saccone GTP: Galanin stimulates pancreatic secretion volume and inhibits amylase secre-tion in the anaesthetised Australian possum. Pancreatology 2009; 9: 438.
34. Griesbacher T, Rainer T, Tiran B, Fink E, Lembeck F, Peskar BA: Mechanism of kinin release during experimental acute pancreati-tis in rats: evidence for pro-as well as anti-inflammatory roles of oedema formation. Br J Pharmacol 2003; 139: 299-308. (Pubitemid 36760362)
35. Kanbe T, Naruse S, Kitagawa M, Nakae Y Hayakawa T: Effects of a bradykinin receptor antagonist (HOE140) on taurocholate-in-duced acute pancreatitis in rats. Pancreas 1996; 13: 283-288. (Pubitemid 26317998)
36. 2 receptor sup-presses acute pancreatitis induced by ob-struction of the pancreaticobiliary duct in rats. Br J Pharmacol 2002; 135: 29-36. (Pubitemid 34102095)
37. Gregersen S, Lindskog S, Land T, Langel U, Bartfai T, Ahren B: Blockade of galanin-in-duced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35. Eur J Pharmacol 1993; 232: 35-39. (Pubitemid 23056994)
38. Bartfai T, Langel U, Bedecs K, Andell S, Land T, Gregersen S, Ahrén B, Girotti P, Consolo S, Corwin R, Crawley J, Xu X, Wiesenfeld-Hallin Z, Hokfelt T: Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci USA 1993; 90: 11287-11291. (Pubitemid 23354414)